China International Exhibition on Pharmaceutical Raw Materials Tickets

CPhI China, in collaboration with PMEC China, serves as a pivotal platform driving the global pharmaceutical industry’s upgrade and innovation. This edition of the exhibition has undergone a strategic enhancement, introducing six dedicated thematic zones to precisely align with cutting-edge trends and procurement needs. Concurrently, more than one hundred high‑profile forums will be held, focusing on policy and regulatory frameworks, innovative R&D, and intelligent manufacturing, thereby deepeni

The Exhibition Value of CPHI China

• A Flagship Platform for the Global Pharmaceutical IndustryAs Asia’s largest specialized pharmaceutical event, it brings together over 3,600 exhibiting companies and more than 110,000 professional visitors from over 150 countries and regions, serving as a strategic platform for companies to showcase their capabilities and connect with global resources.
• One-Stop Coverage Across the Entire Industry ChainExhibits comprehensively cover 18 core sub‑sectors, including APIs, natural extracts, biotechnology, contract manufacturing, finished dosage forms, pharmaceutical machinery, packaging materials, laboratory instruments, and more, enabling efficient matchmaking between upstream and downstream players—from R&D innovation to large‑scale production.
• A Hub for International Resource NetworkingWith a steadily increasing share of international visitors, the show attracts buyers from traditional markets such as India, South Korea, Japan, Europe, and North America, as well as emerging markets along the Belt and Road Initiative. It provides domestic and international enterprises with an efficient pathway to deepen connections within global supply chains and optimize their international footprint.
• A Launchpad for Cutting‑Edge TechnologiesFocusing on前沿 areas such as biopharmaceuticals, peptide therapeutics, cell therapy, intelligent manufacturing, and green processes, the event showcases innovative raw materials and state‑of‑the‑art equipment. Specialized zones—including a debut brand incubation area, a Future Lab space, and a medical‑aesthetic packaging section—offer enterprises an authoritative stage to seize technological leadership.
• In‑Depth Empowerment Through High‑Level ForumsMore than a hundred concurrent conferences address pressing topics such as international expansion, the globalization of innovative drugs, regulatory guidance, natural extracts, and biopharmaceutical R&D, bringing together global regulators, research experts, and industry leaders to provide authoritative insights for strategic decision‑making.
• Precision Business Matching ServicesThrough initiatives like the “Natural Bridge” Global Buyer Matchmaking Program and dedicated overseas buyer sessions, the event facilitates one‑on‑one, precision‑driven connections, effectively advancing collaboration intentions. Overseas buyer delegations and VIP invitation programs further ensure tangible support for enterprises seeking to expand into global markets.
• A Catalyst for Industrial InnovationThe exhibition has witnessed and propelled China’s pharmaceutical industry in its transformation from a “global manufacturing base” to a “global value hub,” serving as a central nexus for linking Chinese pharmaceutical innovations to the global market and integrating them into the worldwide pharmaceutical supply chain.